Last reviewed · How we verify

PD-1-M1-NK Cells

jiuwei cui · Phase 1 active Biologic

PD-1-M1-NK Cells, developed by Jiuwei Cui, is an investigational therapy for advanced gastric and colorectal cancer. Currently in Phase 1, it leverages NK cells to target PD-1, aiming to enhance immune response against tumors.

At a glance

Generic namePD-1-M1-NK Cells
Sponsorjiuwei cui
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.